Open Access | Interview
This work is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License.
Improving human male reproductive health and fertility with increasing age—an interview with Prof. Marco G. Alves
* Corresponding author: Zijian Tian, MD.
Mailing address: Attending Physician, Department of Urology,
The Second Hospital of Tianjin Medical University, Tianjin,
China.
Email: tianzijian1@126.com
Received: 21 May 2024 / Accepted: 30 May 2024 / Published: 27 June 2024
DOI: 10.31491/APT.2024.06.145
Abstract
The article is an interview with Prof. Marco G. Alves, Department of Medical Sciences, Institute of Biomedicine (iBiMED), University of Aveiro, Campus de Santiago Agra do Crasto, Aveiro, Portugal, conducted by Zijian Tian of the Department of Urology, The Second Hospital of Tianjin Medical University, Tianjin, China, on behalf of Aging Pathobiology and Therapeutics.
Marco G. Alves, PhD
Marco G. Alves holds a PhD in Biochemistry, specializing in
bioenergetics, from the University of Coimbra, Portugal.
He has been actively working in the fields of andrology,
male reproductive health, and metabolism. Currently, he
is a Principal Investigator at the Institute of Biomedicine,
University of Aveiro, where he leads the Sertoli Cell and
Gamete Biology lab. Prof. Marco G. Alves has published
over 200 peer-reviewed papers, including works in Nature
Aging, Nature Reviews Urology, Human Reproduction
Update, and Trends in Endocrinology & Metabolism. He
serves on the editorial boards of 15 peer-reviewed journals and is the inventor of two patents. Passionate about
teaching and sharing his knowledge globally, he has delivered over 60 lectures around the world in recent years.
(https://www.researchgate.net/profile/Marco-Alves-11).
Zijian Tian: Can you introduce us to the main area of research that you and your team have been doing lately?
What is the biggest difficulty you are currently facing in
your research?
Marco G. Alves: The Sertoli Cell and Gamete Biology Lab
is dedicated to investigating the fundamental processes
that govern gamete production and functionality. We ultimately aim to provide a scientific foundation for improving
human reproductive health and fertility. To achieve this, we
conduct studies using both normal and pathological human
tissues, which allows us to gain insights into reproductive
health and fertility. In addition to human tissue studies,
we employ cell-based and rodent animal models. These
models enable us to bridge the gap between basic research
and clinical applications, enhancing our understanding of
reproductive processes. Moreover, since in recent years
there has been a growing body of evidence suggesting that
environmental toxins and endocrine disruptors have a significant impact on human reproductive health, our lab has
expanded its research focus to investigate how these agents
influence fertility. More recently, our recent research has
concentrated on examining the impact of metabolic diseases on spermatogenesis and testicular metabolism. We
are particularly interested in understanding the potential
transgenerational effects of metabolic cues in male parents
to the offspring. By studying these metabolic signatures,
we aim to uncover the underlying mechanisms that may
influence reproductive health across generations. Senescence has emerged as a major factor related to metabolic
dysfunction. Thus, we aim to study the impact of male
progenitor age in testis, sperm and offspring. Overall, the
Sertoli Cell has a multifaceted research approach to allow
advance in the field of reproductive biology and contribute
to the development of novel strategies for improving reproductive health and addressing fertility issues.
Zijian Tian: Why did you choose Endocrinology, Metabolism and Male Reproduction as your main research area?
What attracts you most about this field?
Marco G. Alves: After completing my PhD in biochemistry
with a specialization in bioenergetics, I decided to move to
a new university and explore a different area of research.
During that period, I identified a gap in the study of the relevance of metabolic processes in reproduction, particularly
regarding the male partner. I realized there was an opportunity to make a meaningful impact by establishing a new
line of research focused on this overlooked aspect of reproductive health. However, the challenges were considerable.
Many colleagues discouraged me, noting that research
funding predominantly supports studies on female fertility,
with males often considered merely as sperm donors. But
I found that basic research on male fertility was quite limited, leaving space for innovation and discovery.
Given my background in bioenergetics and the understanding that spermatogenesis is a metabolically regulated
process, I identified this as a promising starting point.
Hormones, known to regulate reproductive processes, also
play crucial roles as metabolic regulators. However, there
were gaps in knowledge regarding the interplay between
hormones and testicular metabolism. Recognizing the
trend of delayed parenthood and the common belief that
men can father children at any age, we began investigating
how aging affects male reproductive health, not only for
the individual but also for his offspring.
Zijian Tian: Unlike women, male fertility does not usually
have an endpoint. However, testicular senescence occurs
with the aging process. What methods can we use to uncover the dysregulated pathways of testicular senescence?
Marco G. Alves: It is true that biologically, men can father
children at any age. However, the consequences of delayed parenthood are not fully understood. Additionally,
the molecular mechanisms by which aging alters testicular
physiology and function remain largely unknown. To uncover the dysregulated pathways caused by testicular senescence, several advanced methods and approaches can
be employed. These methods span various fields of molecular biology, omics (proteomics, metabolomics, transcriptomics, epigenomics), and bioinformatics. It is crucial to
complement these techniques with imaging techniques
and functional assays to consolidate the findings. Despite
some significant descriptive observations, the functional
impact of aging on the testis is still largely unexplored.
The challenge lies in linking detected biomarkers to specific functional alterations. A comprehensive approach
involving multi-omics analyses and advanced imaging,
combined with functional assays, is essential to map out
the complex interplay between aging and testicular function. That way we can gain a deeper understanding of the
underlying mechanisms.
Zijian Tian: As we know, disease models play a critical role
in research investigations. What models (animal or cellular) do you typically use to study testicular senescence?
Marco G. Alves: Studying testicular senescence in humans
is particularly challenging. To unravel the mechanisms
involved, we employ a strategy that combines cell and animal-based models with validation using human samples
whenever possible. We use rodent models of different
ages to identify age-related changes and their functional
relevance to the male reproductive system. These models
provide insights into testicular aging and allow us to study
the molecular and cellular mechanisms in a controlled environment. We have access to human Sertoli cells isolated
from testicular biopsies of men with anejaculation due to
obstructive azoospermia or varicocele in the non-biopsied
testis. This enables us to perform in vitro experiments with
human Sertoli cells from men of different ages or under
specific treatments. Additionally, we study human sperm
samples to investigate age-related changes in sperm physiology and seminal fluid. Seminal fluid, often overlooked,
holds potential as an indicator of male reproductive function. By analyzing changes in seminal fluid composition
and sperm quality, we aim to uncover biomarkers and
mechanisms of testicular aging. Overall we can say that
our approach integrates findings from animal and cellbased models with human data, enabling us to validate
and refine our understanding of testicular senescence. This
multifaceted strategy allows us to advance our knowledge
of male reproductive aging and identify potential targets
for intervention.
Zijian Tian: Reproductive research necessarily involves
medical ethics. How do you see the impact of ethical issues
on reproductive research? Do these issues impede the development of reproductive medicine?
Marco G. Alves: Medical ethics is a pillar of integrity in
research, and we cannot ignore its principles. However,
the current level of complexity in ethical discussion has
become a barrier to groundbreaking research and innovation. All good scientists support the role of ethical committees, scrutiny, regulation, and adherence to guidelines.
The problem lies in the extensive bureaucracy that requires scientists to spend excessive time navigating ethical
approval processes instead of focusing on their research.
Ethical committees should function not only as regulators but also as facilitators of excellence and impactful
research. While the regulatory aspect is well-managed, the
facilitative role often falls short. In the field of reproductive medicine, discussions tend to focus more on restrictions than on exploring alternative methods to achieve
research goals. When no alternatives exist, it is essential
to find ways to support and enable the research to proceed
ethically. Medical ethics should be implemented alongside
a supportive structure that helps scientists address and
overcome ethical concerns. This approach would ensure
that ethical standards are maintained while also promoting
innovation and scientific progress.
Zijian Tian: What are the next research priorities for your
research team? Will there be research related to clinical
translation?
Marco G. Alves: Male reproductive health is often not
prioritized by most journals, and research in this field frequently faces discouragement. Publishing outside specialized journals is particularly challenging. One prevalent
misconception is that men can father children at any age without complications. However, it is well-documented
that the likelihood of problems during pregnancy and in
the child increases with the father’s age. Another misconception is that for fertility treatment, one spermatozoon is
sufficient, and men produce thousands. Our work focuses
not only on how aging and metabolic cues affect male
reproductive health but also on the health of the offspring.
Recently, we published a paper analyzing the metabolomics of human seminal fluid, identifying an aging-related
increase in amino acid content. While these findings are
promising, their full relevance remains under debate.
From a cellular perspective, new data suggest that Sertoli
cell lysosomes may impact the aging-related decline in
testosterone production by Leydig cells. We are particularly interested in understanding how these mechanisms
can be pharmacologically altered. This line of research
holds potential for developing targeted treatments to mitigate the effects of aging on male reproductive health and
improve outcomes for both fathers and their offspring.
Zijian Tian: As a young researcher and a clinical doctor,
I have found it difficult to do both jobs well. Do you have
any suggestions on how to balance research and clinical
work?
Marco G. Alves: I often say that research must be driven
by passion. No one does research to get rich; it is the passion for discovery and knowledge that fuels us. The challenge, however, lies in balancing teaching, clinical work,
and research. The key to achieving this balance is meticulous planning. Careful experimental design is essential
to ensure that time is used efficiently. I meticulously plan
each experiment to avoid wasting time and resources. Delegation is also critical. While I review each piece of raw
data, my years of experience have taught me how to effectively delegate tasks within my team. Trust in your team is
paramount. Having a reliable and competent team allows
you to delegate with confidence, ensuring that the work
progresses smoothly even when you are engaged in other
duties as clinical or teaching activities. Aligning clinical
and teaching work with research interests is another strategy to enhance productivity. When your activities overlap,
it creates a natural synergy. Collaboration and brainstorming are vital components of success. The more you collaborate and engage with your partners, the more productive
you become. Collaboration should not be confined to your
institution; use global connectivity to find and work with
the right people. Whether it is for improving experimental
design, generating ideas, or improve and co-authoring papers. Good scientists are generally generous and willing to
assist.
Mentorship also plays an essential role in creating an
efficient scientific environment. Foster a culture of mentorship with your students and seek mentorship from
colleagues. This reciprocal relationship promotes growth
and efficiency. Setting clear goals and regularly assessing
outcomes are crucial. If the current path leads to excessive stress or burnout, reevaluate your approach. Research
should be a source of creativity and pleasure, enhancing
your mental and physical health. While challenging, balancing these aspects of your career is achievable with the
right strategies and mindset.
Zijian Tian: Where do you see the next 5 years in male reproduction?
Marco G. Alves: There have been significant biotechnological advancements in the field of male reproductive
health. For instance, machines now exist that can measure
reactive oxygen species in seminal fluid and determine
parameters associated with sperm quality. However, while
these technologies focus on the endpoint of male fertility—sperm—there remains a substantial need for a deeper
understanding of the basic mechanisms that mediate male
reproduction. More basic research is essential to elucidate
the processes that control testis physiology. There is also
increasing interest in understanding how the health of the
male partner contributes to offspring health. This field
of research is gradually gaining attention and is likely to
gain momentum in the coming decade. The epigenetic
contributions of the father to the offspring are proving to
be far more relevant than initially thought, presenting a
vast area for further exploration and improvement. Another emerging hot topic is the impact of lifestyle on male
reproductive health. Beyond merely describing effects, the
goal is to identify definitive biomarkers that can lead to
more effective treatments for male infertility and mitigate
the impacts of harmful behaviors. The potential for breakthroughs in this area is substantial, offering hope for better
diagnostic tools and therapeutic strategies soon.
Zijian Tian: What would be your best advice for young
doctors and researchers to learn and develop?
Marco G. Alves: It is important to embrace the challenges
that come with balancing clinical, research, and teaching
duties. Few professions undergo as much scrutiny as ours,
with evaluations from institutions, funding agencies, and
peer reviewers for publications. This rigorous process is
unavoidable, but it is crucial to find joy in your discoveries and take pleasure in your work. Happiness in what you
do gives purpose and meaning to the journey. Building
a network across institutions with colleagues you enjoy
working with is pivotal, as you will spend a significant
amount of time collaborating with them. Cultivating these
relationships can make your professional life more fulfilling and productive. Generosity and humility are also pivotal. Strive to be remembered not just for your achievements but for your kindness and positive impact on others.
Not everyone will win a Nobel Prize, secure a tenure track
position, or receive international recognition, and that is
perfectly fine. The true measure of success is finding happiness in your chosen path and making a meaningful contribution, regardless of external accolades. Your greatest
discovery will be the joy and satisfaction you derive from
your work and the positive difference you make in the
lives of others.
Zijian Tian: Thank you for your time.